part.3 12 66 and an unidentified external trigger for NGOA may exist. Whatever its nature, this immune mediated joint insult triggers a hypertrophic repair process which, despite marked cartilage loss, then usually compensates in terms of symptoms and function. Once the inflammatory phase has settled the patient is left with architecturally abnormal joints, which we recognise as 'OA' (fig 2) .
Inclusion of NGOA within the autoimmune umbrella may further stimulate interest in what has previously been regarded by some as an unexciting 'degenerative' condition. From currently available information it would seem that further studies of genetic, constitutional, and immunological factors are warranted if we are to improve our understanding of NGOA, and hence the inherent repair process of synovial joints.
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